相关实验视频

Updated: Jul 8, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

对肝细胞癌的辅助和新辅助疗法

Arndt Vogel^1,2,3, Robert C Grant^2,4, Tim Meyer^5,6

¹Department of Gastroenterology and Hepatology, Toronto General Hospital, Toronto, ON, Canada.

Hepatology (Baltimore, Md.)

|December 18, 2023

概括

免疫检查点抑制剂在手术后的早期肝细胞癌 (HCC) 中表现有前途. IMbrave050试验显示,阿特佐利祖马布和贝瓦齐祖马布的无复发生存率有所改善,支持它们在HCC的辅助治疗中使用.

科学领域:

肝胆道癌症肝胆道癌症
免疫治疗是一种免疫疗法.
临床试验中的临床试验.

背景情况:

免疫瘤治疗方案是高级HCC的标准.
有效性和安全性支持探索早期疾病阶段.
之前的辅助试验 (例如,STORM) 有负面结果.

研究的目的:

审查当前关于早期HCC系统治疗的证据.
概述辅助和新辅助治疗的未来方向.
讨论最近的试验结果对临床实践的影响.

主要方法:

专注于辅助和新辅助系统疗法.
分析了关键的第三期试验数据,包括IMbrave050.0.
对新辅助方法的早期阶段数据的审查.

主要成果:

在IMbrave050试验中,阿特佐利祖马布加贝瓦西祖马布的无复发生存率有所改善.
积极的中间分析结果快速报告.
新辅助剂的数据表明,可能出现主要的病理反应.

结论:

辅助剂阿特佐利祖马布加贝瓦齐祖马布在早期的HCC中显示出有效性.
这些发现促使对辅助治疗期望和终点进行重新评估.
需要在新辅助和辅助环境中进行进一步的研究.

更多相关视频

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...